Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Retained Earnings (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Retained Earnings for 13 consecutive years, with $5.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Retained Earnings rose 33.54% year-over-year to $5.2 million, compared with a TTM value of $5.2 million through Sep 2025, up 33.54%, and an annual FY2024 reading of -$1.9 million, up 99.8% over the prior year.
  • Retained Earnings was $5.2 million for Q3 2025 at Tandem Diabetes Care, up from $3.7 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $5.2 million in Q3 2025 and bottomed at -$1.2 billion in Q1 2025.
  • Average Retained Earnings over 5 years is -$376.8 million, with a median of -$5.1 million recorded in 2022.
  • The sharpest move saw Retained Earnings tumbled 288552.27% in 2021, then surged 398.88% in 2025.
  • Year by year, Retained Earnings stood at -$634.6 million in 2021, then surged by 99.71% to -$1.8 million in 2022, then plummeted by 52283.05% to -$951.8 million in 2023, then surged by 99.8% to -$1.9 million in 2024, then surged by 365.43% to $5.2 million in 2025.
  • Business Quant data shows Retained Earnings for TNDM at $5.2 million in Q3 2025, $3.7 million in Q2 2025, and -$1.2 billion in Q1 2025.